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In higher eukaryotes the hypetmodified guanine analogue, queuine (7-(5-(((1S,4S,5R)-4,5-dihydroxy-2-cyclopentene-l-yl)amino)-methyl)-7-deaza- 
guanine), occurs free or as modified nucleoside (Q) in the anticodon of specific tRNAs. Fast proliferating tissues and tumors contain considerable 
amounts of free queuine and Q-deficient RNAs. Here we show that HeLa cells can be grown in the absence or presence of queuine. In response 
to queuine, and under appropriate conditions, (i) the proliferation of HeLa cells was stimulated, (ii) the steady-state l vel of c-j& mRNA was 
reduced, contrary that of c-myc mRNA was elevated, and (iii) in cytosolic extracts protein phosphorylation especially for a 42 kDa protein was 
significantly increased. The results suggest hat queuine substitutes for growth factors in a signal transduction pathway. 
Queuine; Growth control; Signal transduction; Oncogene; Protein phosphorylation 
1. INTRODUCTION 
The modified base, queuine (7-(5(((lS,4SSR)- 
4,5-dihydroxy-2-cyclopentene- 1 yl)amino)-methyl)-7- 
deazaguanine), cannot be synthesized by mammals, but 
is obtained from their diet or gut flora (for summa- 
rizing references see [1,2]). Mammalian cells are sup- 
plied with queuine by fetal calf serum when grown in 
culture [3]. Queuine is inserted into position 34 (wobble 
base) of the anticodon of tRNAs accommodating for 
the amino acids asparagine, aspartic acid, histidine and 
tyrosine [4]. This insertion is mediated by the eukaryotic 
tRNA-guanine transglycosylase (EC 2.4.2.29) in a base 
for base exchange reaction with guanine [5]. The occur- 
rence of queuine and of queuosine tRNAs is highly con- 
served from eubacteria to eukaryotes, yeast being the 
only known exception. Alterations of the metabolism 
of queuine are tissue specific and are dependent on the 
metabolic state of cells and tissues. Alterations in the 
queuine-modification of tRNAs and fluctuations in the 
amount of free queuine in eukaryotic cells occur 
especially during development and differentiation [6]. 
In neoplastically transformed, fast dividing cells free 
queuine and Q-deficient tRNAs accumulate. Nishimura 
was the first who surmised that the presence of Q- 
deficient tRNAs in tumor cells is not the result of their 
proliferative state, but rather a specific property of 
tumors and undifferentiated cells [l]. Inhibition of 
queuine modification of tRNAs has been implicated in 
the promotion of carcinogenesis in vitro [7]. For 
human lymphomas we have found that the relative 
amount of Q-deficient tRNAs is generally greater in 
high grade than in low grade lymphomas; these lym- 
phomas contain relatively high amounts of free queuine 
and Q-deficient tRNAs. Both the accumulation of Q- 
deficient tRNAs and of queuine are correlated with the 
proliferative activity of the lymphoma tissue [8]. 
Deranged proliferation during carcinogenesis appears 
to involve abnormal signal transduction pathways 
[9,10]. We have therefore established HeLa cells as a 
model system to investigate whether queuine affects cell 
proliferation and related processes uch as the expres- 
sion of oncogenes and specific protein phosphoryla- 
tions. The present data support this view. 
2. MATERIALS AND METHODS 
2.1. Materials 
Eagle’s minimum essential medium, modified for autoclaving 
(MEM) was from Gibco/BRL Laboratories (Eggenheim, FRG). 
Horse serum was from Boehringer Mannheim (FRG) and was analyz- 
ed for queuine-deficiency [6]. It was essentially queuine-free. HeLa- 
S3 cells were kindly supplied by Dr Ogilvie (author’s address). 
Plasmids, carrying the c-fos or c-myc oncogenes (Amprobe) were 
from Amersham Corp. (UK). Protease inhibitors, leupeptin, 
pepstatin, aprotinin and a2-macroglobulin were from Boehringer 
Mannheim (FRG). 
2.2. Cultivation of cells 
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HeLaS3 cells were routinely grown in 10 ml MEM medium, sup- 
plemented with 10% horse serum, in culture dishes of 8.5 cm in 
diameter. Incubation was in an atmosphere of 5% COZ and 95% air. 
Queuine was added to a final concentration of 3.6 x lo-’ M. For 
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determination of the cell number, cells were collected by trypsinisa- 
tion and counted in a Fuchs/Rosenthal chamber. 
2.3. Preparation of RNA and Northern blot analysis 
Total RNA was extracted from l-2 x 10’ cells by the guanidinium 
thiocyanate procedure, modified as follows: cells were first suspend- 
ed in lysis buffer (10 mM Tris-HCl, pH 7.5, 0.15 M NaCl, 1.5 mM 
MgClz, 0.65% NP-40) [11] and kept on ice for 15 min. Cells were 
then lysed on a vortex mixer for 1 min or by pipetting them up and 
down several times. Cell debris and nuclei were removed by cen- 
trifugation at 3000 x g for 10 min. The supernatant was subjected to 
the guanidinium thiocyanate procedure, omitting the protease treat- 
ment. RNA was separated in 1% agarose/formaldehyde gels and 
blotted onto GeneScreen plus (New England Nuclear) according to 
standard procedures. Filter-bound RNA was hybridized to a nick- 
translated plasmid carrying part of either the c-fos or the c-myc gene. 
2.4. Phosphorylation assay 
1- 1.5 x 10’ cells were collected from monolayer cultures and lysed 
in hypotonic buffer (10 mM Hepes, pH 7.9, 1.5 mM MgC12, 10 mM 
KCI, 7 mM fl-mercaptoethanol) in the presence of protease inhibitors 
(1 pg/ml each of pepstatin, leupeptin, aprotinin and 
oz-macroglobulin). Cytosolic proteins were obtained by graduate 
centrifugation as described in [12]. For in vitro phosphorylation, 
200 pg of cytosolic proteins were suspended in a final volume of 40 ~1 
hypotonic buffer. All subsequent steps were performed on ice. 5 pl 
of cycloheximide (final concentration 10 pg/ml) and 5 ~1 of 0.1 M 
MgCl2 was added. Labeling was started by the addition of 10&i 
[T-~‘P]ATP (3000 mCi/mmol) and stopped after 10 min by adding 
6 ~1 0.2 M EDTA. One-half of the sample was subjected to 12.5% 
SDS-polyacrylamide gel electrophoresis, followed by staining with 
Coomassie blue, destaining, drying and autoradiography. 
3. RESULTS 
3.1. Stimulation of cell proliferation 
HeLa cells were grown in media supplemented with 
queuine-free horse serum in monolayer cultures 
without (-Q) or with added queuine (+Q) at a concen- 
tration of 3 x lo-’ M. Obviously the total amount of 
cells per culture dish was about 2-fold higher in +Q- 
cultures than in -Q-cultures. When queuine was added 
to the -Q-culture after cell division had ceased, the 
cells started to divide again and also reached the final 
cell density per culture dish that corresponded to the 
+Q-culture (Fig. 1). Under the conditions described, 
queuine acted as a proliferation-stimulating agent on 
HeLa cells. Similar results can be obtained in the 
absence of serum factors (not shown). 
3.2. Expression of the cellular proto-oncogenes c-fos 
and c-myc 
The cellular proto-oncogenes, c-fos and c-myc are 
believed to be important in cell cycle control 
mechanisms and in the mitogenic response [10,13]. We 
reasoned that the stimulating activity of queuine on the 
proliferation of HeLa cells might be accompanied by 
changes in the expression of these two genes. Therefore 
total RNA was extracted from HeLa cells, which were 
grown in the presence or absence of queuine. After 
electrophoresis the c-fos and c-myc mRNA levels were 
investigated by Northern-blot analysis. The results 
show that +Q-cells contained a significantly lower level 
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Fig. 1. Growth of HeLa cells in the presence (+Q) or absence of 
queuine (-Q). 5 x 10’ cells were seeded to each culture dish and 
incubated for 3 days without queuine. On the fourth day the medium 
was changed and one portion of the cultures received queuine (o), 
while the other portion did not (0). On the sixth day an additional 
portion of previously queuine free cultures was supplied with queuine 
(---). The medium was changed on the seventh day. 
of c-fos however, a significantly higher level of c-myc 
mRNA than -Q-cells (Fig. 2). Since +Q- and -Q-cells 
were grown under identical conditions, the altered 
levels of c-fos and c-myc mRNA can be traced back ex- 
clusively to the presence or absence of queuine in the 
growth medium. 
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Fig. 2. Queuine-dependent expression of the c-fos and c-myc genes in 
HeLa cells. 1 x lo6 cells were seeded to each culture dish and 
incubated either with (+Q) or without queuine (-Q) for 4 days with 
exchange of the medium on the second day. RNA was extracted and 
40 pg each were separated by electrophoresis followed by Northern- 
blot analysis (see section 2). Filter-bound RNA was hybridized to 
labeled plasmids carrying either the c-fos (A) or the c-myc gene (B). 
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Fig, 3. In vitro phosphorylation of cytosolic proteins from HeLa cells 
grown with (+Q) or without queuine (-Q). HeLa cells were grown 
in this experiment as described in the legend to Fig. 2. Ceil- 
fractioning. 32P-labeling and electrophoresis was done as described in 
section 2. The autoradiography of the dried gel is shown. The arrow 
(t) indicates a protein specifically labeled in (+Q) cells. 
The signaling pathway that leads from the binding of 
growth factors to the c-fos and c-myc gene activation 
and subsequent cellular responses involves a complex 
network of protein phosphorylations 19, lo]. Therefore 
we have studied protein phosphorylation by using 
cytosolic extracts from +Q- and -Q-cells. The extracts 
were incubated with [T-~‘P]ATP at 0°C for 10 min and 
the labeled proteins were analyzed by one-dimensional 
electrophoresis. Indeed specific, queuine-dependent 
alterations in protein phosphorylation were observed 
(Fig. 3). Especially one protein with a molecular mass 
of about 42 kDa became heavily phosphorylated in ex- 
tracts from +Q-cells, but much less in extracts of 
-Q-cells. 
4. DISCUSSION 
The growth of I-IeLa cells in culture depends on the 
availability of growth factors in the medium. These 
growth factors bind to specific receptors on the cell sur- 
face which in turn leads to a signal that is transduced 
into the cell [lo]. The earliest cellular responses that can 
be observed are: (i) the activation of protein kinases, 
especially protein kinase C; and (ii) the transient and 
rapid increased expression of the primary response 
genes c-fos and c-myc [IO, 13). This is followed by the 
cellular response, i.e. initiation of DNA synthesis and 
submission to the cell cycle, Any alterations in this 
signal transduction pathway have been linked with 
cancer. A more relaxed control of cell proliferation and 
a reduced dependency on growth factors is typically 
observed with tumor cells, The finding that queuine can 
stimulate proliferation suggests that it may interfere 
with or participate in this signaling pathway that ac- 
tivates the mitogenic potential of the cell. It appears as 
if queuine stimulates or even can mimic the effect of 
growth factors on cell proliferation. This stimulatory 
effect coincides with a queuine-dependent modulation 
in the expression of the proto oncogenes c-fos and c- 
myc in the growing cells. These two genes are assumed 
to be primary targets of the signaling pathway initiated 
by growth factors and other mitogens such as phorbol 
esters and are important in the cell cycle control 
[9,10,13]. It seems likely that the proliferation- 
stimulating activity of queuine is mediated primarily by 
the differential expression of these two genes. The 
reduced level of the c-fos mRNA in +Q-cells might be 
caused by an increased translation resulting in a 
destabilization of this RNA [15]. The specific effect of 
queuine on protein phosphorylation can be taken as 
further evidence for the involvement of queuine in 
cellular signaling. The phosphorylation of a 42 kDa 
protein in response to mitogenic stimuli has indeed 
been reported [14]. 
As a consequence of our findings we propose that the 
eukaryotic nutrient factor queuine is involved in in- 
tracellular signaling and may indeed play a role in the 
generation or maintenance of malignant transfor- 
mation. 
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